Search

Displaying results 7501 - 7510 of 9667 in total
  1. Drug

    IP-2018

    go.drugbank.com/drugs/DB19049
    Investigational

    IP-2018 is under investigation in clinical trial NCT04686916 (Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients).

  2. Drug

    GLP-1 (7-36) amide

    go.drugbank.com/drugs/DB19258
    Investigational

    GLP-1 (7-36) amide is under investigation in clinical trial NCT01185119 (Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET).

  3. Drug

    Lactobacillus coryniformis K8

    go.drugbank.com/drugs/DB15733
    Experimental

    Lactobacillus is a common bacteria found in the gut with Lactobacillus coryniformis K8 being originally isolated from artisan goat cheese.

  4. Drug

    Indium

    go.drugbank.com/drugs/DB11659
    Investigational

    Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.

  5. Drug

    Safingol

    go.drugbank.com/drugs/DB11924
    Investigational

    Safingol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  6. Drug

    Oleandrin

    go.drugbank.com/drugs/DB12843
    Investigational

    Oleandrin has been used in trials studying the treatment of Lung Cancer and Chemotherapeutic Agent Toxicity.

  7. Drug

    Tofimilast

    go.drugbank.com/drugs/DB11681
    Investigational

    Tofimilast has been used in trials studying the treatment of Asthma and Pulmonary Disease, Chronic Obstructive.

  8. Drug

    Birinapant

    go.drugbank.com/drugs/DB11782
    Investigational

    Birinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).

  9. Drug

    Tofogliflozin

    go.drugbank.com/drugs/DB11824
    Investigational

    Tofogliflozin has been used in trials studying the treatment and prevention of Diabetes Mellitus Type 2.

  10. Drug

    Vilaprisan

    go.drugbank.com/drugs/DB11971
    Investigational

    Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.